| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
049
|
Date of Entry 06/07/2018
|
|
FR Recognition Number
|
3-150
|
| Standard | |
ISO 7199 Third edition 2016-11-15 Cardiovascular implants and artificial organs - Blood-gas exchangers (oxygenators) |
|
Identical AdoptionANSI AAMI ISO 7199:2016 Cardiovascular implants and artificial organs - Blood-gas exchangers (oxygenators). |
|
Scope/AbstractThis document specifies requirements for sterile, single-use, extracorporeal blood-gas exchangers (oxygenators) intended for supply of oxygen to, and removal of carbon dioxide from, the blood of humans. This document also applies to heat exchangers and arterial filters that are integral parts of the oxygenator. This document also applies to external equipment unique to the use of the oxygenator. |
|
| Extent of Recognition
|
Rationale for Recognition
| This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
| FDA recognition of ISO 7199 Third edition 2016-11-15 [Rec# 3-150] will be superseded by recognition of ISO 7199 Fourth edition 2024-09 [Rec# 3-194]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 3-150] until December 20, 2026. After this transition period, declarations of conformity to [Rec# 3-150] will not be accepted. |
|
Public Law, CFR Citation(s) and Procode(s)*
| Regulation Number |
Device Name |
Device Class |
Product Code |
| §870.4350 |
Oxygenator, Cardiopulmonary Bypass
|
Class 2
|
DTZ
|
|
Relevant FDA Guidance and/or Supportive Publications*
Guidance for Cardiopulmonary Bypass Oxygenators 510(k) Submissions; Final Guidance for Industry and FDA Staff, issued November 2000.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contacts
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |